Publications by authors named "Manuel Comabella"

Claim this Profile
R
Reduced CD40 expression in B cell subsets of individuals with radiologically isolated syndrome.
Christian W Keller, Kerstin Stein, Andreu Vilaseca, Luisa M Villar, Gary Álvarez-Bravo, Manuel Comabella

Front Immunol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New serum soluble factors predicting inflammatory and non-inflammatory disability worsening in multiple sclerosis.
Alexander Rodero-Romero, María Domínguez-Mozo, Enric Monreal, José M García-Domínguez, Noelia Villarrubia, Manuel Comabella

Front Immunol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarker discovery using NUcleic Acid-Linked Immuno-Sandwich Assay in multiple sclerosis patients experiencing progression independent of relapse activity.
Sofia Sandgren, Aleksandra Maleska Maceski, Pascal Benkert, Maximilian Einsiedler, Sabine Schaedelin, Manuel Comabella

Mult Scler· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Effectiveness and associated factors of response to Fampridine in multiple sclerosis: A prospective observational study from an expert center".
Elisa Martinez-Campos, Miguel Angel Robles, Rosalia Horno, Roger Meza, Samuel Sánchez, Manuel Comabella

Mult Scler Relat Disord· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cladribine Preserves Normal Central Nervous System Cellular Activity and Promotes Neuroprotection to Oxidative Stress Damage.
Herena Eixarch, Laura Calvo-Barreiro, Nicolás Fissolo, Ursula Boschert, Arnau Hervera, Manuel Comabella

Int J Mol Sci· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood biomarkers for predicting disability worsening in progressive multiple sclerosis: a multinational, individual participant-level analysis.
Ahmed Abdelhak, Franziska Bachhuber, Kiarra Ning, Pascal Benkert, W John Boscardin, Manuel Comabella

J Neurol Neurosurg Psychiatry· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebrospinal 14-3-3 Protein Levels as a Neuroaxonal Biomarker in Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder.
Javier Villacieros-Álvarez, Maria Sepulveda, Adrián Valls-Carbó, Nicolas Fissolo, Alessandro Dinoto, Manuel Comabella

Neurol Neuroimmunol Neuroinflamm· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severity-Dependent Neuroaxonal Damage Assessed by Serum Neurofilaments in ICANS Patients Undergoing CD19-Targeted CAR T-Cell Therapy.
Andreu Vilaseca, Helena Ariño, Gloria Iacoboni, Samantha Feijóo, Ana Zabalza, Manuel Comabella

Eur J Neurol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of cellular factors associated with inflammation and neurodegeneration in multiple sclerosis.
Alexander Rodero-Romero, José Ignacio Fernández-Velasco, Enric Monreal, Raquel Sainz-Amo, Roberto Álvarez-Lafuente, Manuel Comabella

Front Immunol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized treatment decision algorithms for the clinical application of serum neurofilament light chain in multiple sclerosis: A modified Delphi Study.
Özgür Yaldizli, Pascal Benkert, Lutz Achtnichts, Amit Bar-Or, Viviane Bohner-Lang, Manuel Comabella

Mult Scler· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated Syndrome.
Nicolás Fissolo, Sabine Schaedelin, Luisa M Villar, Jan D Lünemann, Jorge Correale, Manuel Comabella

JAMA Neurol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep learning to predict progression independent of relapse activity at a first demyelinating event.
Llucia Coll, Deborah Pareto, Francisco Aparicio-Serrano, Susana Otero-Romero, Alvaro Cobo-Calvo, Manuel Comabella

Brain Commun· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Variant rs7665090 Is Associated With Interferon-Beta Response in Multiple Sclerosis Patients.
Andreu Vilaseca, Elena Urcelay, Sunny Malhotra, Mireia Castillo, Montserrat Aroca, Manuel Comabella

Eur J Neurol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining CSF and Serum Biomarkers to Differentiate Mechanisms of Disability Worsening in Multiple Sclerosis.
Enric Monreal, José Ignacio Fernández-Velasco, Susana Sainz de la Maza, Mercedes Espiño, Noelia Villarrubia, Manuel Comabella

Int J Mol Sci· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Barcelona baseline risk score to predict long-term prognosis after a first demyelinating event: a prospective observational study.
Carmen Tur, Pere Carbonell-Mirabent, Susana Otero-Romero, Álvaro Cobo-Calvo, María Jesús Arévalo, Manuel Comabella

Lancet Reg Health Eur· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiologically isolated syndrome: How could we accurately diagnose a subclinical period of multiple sclerosis?
Andreu Vilaseca, Angela Vidal-Jordana, Sofia Sceppacuercia, Willem Calderon, Georgina Arrambide, Manuel Comabella

Mult Scler· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Sphingosine-1-Phosphate Receptor Modulators as Potential CHI3L1 Inhibitors by Ligand-Based Virtual Screening and Molecular Dynamics Simulations.
Elnaz Aledavood, Carmen Gil, Manuel Comabella, Ana Martinez

ACS Omega· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uncovering alternative diagnoses in patients with clinical syndromes suggestive of multiple sclerosis: A transversal study from the prospective Barcelona CIS cohort.
Andreu Vilaseca, Mar Tintoré, Pere Carbonell-Mirabent, Marta Rodríguez-Barranco, Mª Jesús Arévalo, Manuel Comabella

Mult Scler· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance of treatment response scoring systems among patients with multiple sclerosis treated with high-efficacy therapies.
Mariano Marrodan, Augusto Sao Avilés, Jordi Río, Álvaro Cobo-Calvo, Victoria Fernández, Manuel Comabella

Mult Scler· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contribution of Blood Biomarkers to Multiple Sclerosis Diagnosis.
Manuel Comabella, Agustín Pappolla, Enric Monreal, Nicolás Fissolo, Augusto Cesaar Sao-Avilés

Neurol Neuroimmunol Neuroinflamm· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short-chain fatty acids in multiple sclerosis: Associated with disability, number of T2 lesions, and inflammatory profile.
Maria Inmaculada Dominguez-Mozo, Daniel López-Mecández, Luisa María Villar, Lucienne Costa-Frossard, Noelia Villarrubia, Manuel Comabella

Ann Clin Transl Neurol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age-Related Disability Outcomes After a First Demyelinating Event.
Alvaro Cobo-Calvo, Pere Carbonell-Mirabent, Carmen Tur, Susana Otero-Romero, Rene Carvajal, Manuel Comabella

Neurology· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complement Activation Profiles Predict Clinical Outcomes in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.
Javier Villacieros-Álvarez, Jan D Lunemann, Maria Sepulveda, Adrián Valls-Carbó, Alessandro Dinoto, Manuel Comabella

Neurol Neuroimmunol Neuroinflamm· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EBV-specific T-cell immunity: relevance for multiple sclerosis.
Malina Behrens, Manuel Comabella, Jan D Lünemann

Front Immunol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased EBNA1-specific antibody response in primary-progressive multiple sclerosis.
Manuel Comabella, Harald Hegen, Luisa M Villar, Konrad Rejdak, Augusto Sao-Avilés

J Neurol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis